Clinical Trials Logo

Colonic Neoplasms clinical trials

View clinical trials related to Colonic Neoplasms.

Filter by:

NCT ID: NCT04716010 Completed - Cancer of Colon Clinical Trials

Developing and Evaluating Product Messaging

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

Purpose: To assess the impact of taxes, warnings, and a combination of taxes and warnings on US adults' decisions to purchase products that contain red meat in an online grocery store. Procedures (methods): Participants will be recruited from Prime Panels (an online panel research company). Following online consent, participants will be assigned to one of four trial arms: 1) Control (no warning and no tax), 2) Warnings (all products that contain red meat have a health warning and environmental warning), 3) Tax (30% tax on products that contain red meat), and 4) Combined warning and tax (all products that contain red meat will have the two warnings and a 30% tax). Then, participant will enter an online grocery store reflecting their assigned arm. The participant will be instructed to complete a shopping task in the online grocery store. After completing the shopping task, participants will be redirected to an online survey and answer a series of questions about the shopping task, labels (excluding tax and control groups), and taxes (excluding warning and control groups). Questions will also include standard demographic and health related variables.

NCT ID: NCT04683783 Completed - Rectal Cancer Clinical Trials

National Registry of Liver First Approach

RENACI
Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

Liver metastases are present in 15-25% of patients with colorectal cancer at the time of diagnosis of the primary tumor, which is defined as synchronous liver metastases. Treatment for the potential cure of this disease includes surgical resection of both the primary tumor and liver metastases. The liver first approach was described by Mentha for patients with asymptomatic rectal tumors with with initially unresectable or borderline resectable liver metastases. There is little data in the scientific literature on how many patients scheduled for this strategy complete both surgeries and/or undergo the full chemo/radiation therapy.

NCT ID: NCT04606992 Completed - Clinical trials for Colon Cancer Stage I

Combined Endoscopic and Laparoscopic Surgery (CELS) for Early Colon Cancer in High Risk Patients

Start date: February 10, 2020
Phase: N/A
Study type: Interventional

This is a pilot feasibility study on high risk patients due to frailty and comorbidity who have early stage colon cancer (UICC 1). We will use a novel resection technique with expected less risk of complications called the Combined Endoscopic and Laparoscopic Surgery (CELS). After the histopathologic evaluation. Patients will be placed in either low risk or high risk group. Depending on this, they will be followed for 3 years or referred to standard resection

NCT ID: NCT04601272 Completed - Clinical trials for Breast Cancer Screening

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

Start date: September 29, 2020
Phase:
Study type: Observational

The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.

NCT ID: NCT04548531 Completed - Colon Cancer Clinical Trials

Engaging Patients in Colon Cancer Screening Decisions During COVID-19

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

The goal of the study is to examine whether a shared decision making intervention improves decision making about colon cancer screening for patients who had their colonoscopy delayed or postponed due to the COVID pandemic. Eligible patients (n=800) will be randomly assigned to either the intervention or control arm. A subset will be surveyed about 6-8 weeks post intervention to measure shared decision making, their intention to follow through with screening, and their decisional conflict. Study staff will conduct medical chart review to track receipt of colon cancer screening within 6 months. The statistician will test whether patients in the intervention arm report more shared decision making, less decisional conflict, higher intention to follow through on screening and have higher screening rates compared to those in the control arm.

NCT ID: NCT04540081 Completed - Obesity Clinical Trials

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

CLOVER
Start date: October 5, 2020
Phase: N/A
Study type: Interventional

The purpose of CLOVER is to utilize Epic Healthy Planet to increase adherence to United States Preventive Services Task Force (USPSTF) and Centers for Disease Control and Prevention (CDC) recommendations in adults age 50 and older.

NCT ID: NCT04538404 Completed - Surgery Clinical Trials

Mortality Score in Elderly Patients With Colon Cancer

MECC
Start date: January 1, 2011
Phase:
Study type: Observational

CR-POSSUM is one of the most used surgical scores to predict mortality after colorectal surgery. Its main drawback is the requirement of intraoperative variables, whose collection is time-consuming and prevents from obtaining a purely preoperative risk assessment. The primary aim of the study is to develop a new surgical score using preoperative parameters to predict 30-day mortality after colon cancer surgery in the elderly population. The secondary objective is to analyze its efficacy compared to CR-POSSUM.

NCT ID: NCT04526314 Completed - Clinical trials for Colon Adenocarcinoma

Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

Start date: January 1, 2018
Phase:
Study type: Observational

The objective of this study was to assess survival trends in elderly patients with stage III colon cancer

NCT ID: NCT04518579 Completed - Clinical trials for Immunity Factors in Cancer Colon Patients

Epidural-inhalational Versus Epidural-intravenous Anaesthesia on Anti-tumor Immunity in Patients With Cancer Colon

tumorimmunity
Start date: April 15, 2018
Phase: N/A
Study type: Interventional

Surgery is the primary treatment for colon cancer. However, the rate of recurrence or metastasis in colon cancer can be as high as 30%, even in stages 1 and 2 . Most colon cancer-related deaths are caused by metastatic disease . Many patients with colon cancer harbour micrometastases and disseminated tumour cells at the time of surgery . Whether the micrometastases develop into clinically significant metastases depends on the immune system's ability to eradicate them.The aim of the study is to declare the effect of epidural-intravenous based anesthetic technique on anti-tumor immunity and in comparison to epidural inhalational based anesthetic technique in patients undergoing open surgical resection of colon cancer.

NCT ID: NCT04517708 Completed - Gastric Cancer Clinical Trials

Effectiveness of Nutritional Interventions for Cancer Patients Undergoing Chemotherapy

Start date: January 15, 2016
Phase: N/A
Study type: Interventional

This study aims to estimate the effects of nutritional interventions on the improvement of nutritional status and quality of life (QoL) among gastrointestinal patients in Vietnam